Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

BACKGROUND: Small cell lung cancer (SCLC) transformation during epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment in lung cancer has been suggested as one of possible resistance mechanisms. METHODS: We evaluated whether SCLC transformation or neuroendocrine (NE) differe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chang, Youjin, Kim, Seon Ye, Choi, Yun Jung, So, Kwang Sup, Rho, Jin Kyung, Kim, Woo Sung, Lee, Jae Cheol, Chung, Jin-Haeng, Choi, Chang-Min
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Academy of Tuberculosis and Respiratory Diseases 2013
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790027/
https://ncbi.nlm.nih.gov/pubmed/24101933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2013.75.3.95
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg